FFCP PHASE1:Mm9::chr17:34941009..34941023,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=55|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr17:34941009..34941023,-|id=chr17:34941009..34941023,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002369!6.01e-40!7;UBERON:0006858!6.01e-40!7;UBERON:0002342!8.11e-28!10;UBERON:0005062!8.11e-28!10;UBERON:0003064!1.03e-19!14;UBERON:0005157!6.52e-10!27;UBERON:0005631!2.81e-08!3;UBERON:0000478!2.81e-08!3;UBERON:0000158!2.81e-08!3;UBERON:0000305!6.93e-07!1|ontology_enrichment_uberon_v019_2=UBERON:0002369,1.33e-86,7;UBERON:0006858,1.33e-86,7;UBERON:0003064,1.38e-43,14;UBERON:0005256,8.60e-14,45;UBERON:0005172,1.11e-12,49;UBERON:0005173,1.11e-12,49;UBERON:0002417,1.11e-12,49;UBERON:0000916,1.11e-12,49;UBERON:0002368,2.18e-10,60;UBERON:0003104,3.20e-10,61;UBERON:0009142,3.20e-10,61;UBERON:0002530,1.34e-09,65;UBERON:0009569,1.86e-09,66;UBERON:0000949,1.12e-08,72;UBERON:0005177,6.48e-08,79;UBERON:0002100,5.94e-07,90;UBERON:0010314,8.41e-07,92|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0850432901510698,0,0,0.159992422793407,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,6.08612770165782,1.21439728736295,3.65358573974569,4.38169444786511,5.42601505989441,6.34979018532806,3.89566433121994,0.988779870937496,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228497025219458,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.21183207086382,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.167884616364078,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.135804113845862,0,0,0,0,0,0,0,0,0,0,0.220591419119515,0|short_description=p@chr17:34941009..34941023,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=55 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr17:34941009..34941023,- | |||
|description=CAGE_peak_at_chr17:34941009..34941023,- | |||
|id=chr17:34941009..34941023,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002369!6.01e-40!7;UBERON:0006858!6.01e-40!7;UBERON:0002342!8.11e-28!10;UBERON:0005062!8.11e-28!10;UBERON:0003064!1.03e-19!14;UBERON:0005157!6.52e-10!27;UBERON:0005631!2.81e-08!3;UBERON:0000478!2.81e-08!3;UBERON:0000158!2.81e-08!3;UBERON:0000305!6.93e-07!1 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002369,1.33e-86,7;UBERON:0006858,1.33e-86,7;UBERON:0003064,1.38e-43,14;UBERON:0005256,8.60e-14,45;UBERON:0005172,1.11e-12,49;UBERON:0005173,1.11e-12,49;UBERON:0002417,1.11e-12,49;UBERON:0000916,1.11e-12,49;UBERON:0002368,2.18e-10,60;UBERON:0003104,3.20e-10,61;UBERON:0009142,3.20e-10,61;UBERON:0002530,1.34e-09,65;UBERON:0009569,1.86e-09,66;UBERON:0000949,1.12e-08,72;UBERON:0005177,6.48e-08,79;UBERON:0002100,5.94e-07,90;UBERON:0010314,8.41e-07,92 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0850432901510698,0,0,0.159992422793407,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,6.08612770165782,1.21439728736295,3.65358573974569,4.38169444786511,5.42601505989441,6.34979018532806,3.89566433121994,0.988779870937496,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228497025219458,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.21183207086382,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.167884616364078,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.135804113845862,0,0,0,0,0,0,0,0,0,0,0.220591419119515,0 | |||
|short_description=p@chr17:34941009..34941023,- | |||
}} |
Latest revision as of 17:59, 4 August 2015
Short description: | p@chr17:34941009..34941023, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr17:34941009..34941023, - |
Coexpression cluster: | MCL_coexpression_mm9:55 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
adrenal gland | 1.33e-86 | 7 |
adrenal/interrenal gland | 1.33e-86 | 7 |
intermediate mesoderm | 1.38e-43 | 14 |
trunk mesenchyme | 8.60e-14 | 45 |
abdomen element | 1.11e-12 | 49 |
abdominal segment element | 1.11e-12 | 49 |
abdominal segment of trunk | 1.11e-12 | 49 |
abdomen | 1.11e-12 | 49 |
endocrine gland | 2.18e-10 | 60 |
mesenchyme | 3.20e-10 | 61 |
entire embryonic mesenchyme | 3.20e-10 | 61 |
gland | 1.34e-09 | 65 |
subdivision of trunk | 1.86e-09 | 66 |
endocrine system | 1.12e-08 | 72 |
trunk region element | 6.48e-08 | 79 |
trunk | 5.94e-07 | 90 |
structure with developmental contribution from neural crest | 8.41e-07 | 92 |